Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-30

Clinical Trial Update: Intranasal Ketamine for Acute Traumatic Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intranasal ketamine for acute traumatic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (intranasal) (ketamine)

Snippet

Sponsor: Tel Aviv Medical Center | Conditions: Acute Pain | Phase 4 | Status: COMPLETED